75 related articles for article (PubMed ID: 10606722)
1. Substitution of a conserved amino acid residue alters the ligand binding properties of peroxisome proliferator activated receptors.
Causevic M; Wolf CR; Palmer CN
FEBS Lett; 1999 Dec; 463(3):205-10. PubMed ID: 10606722
[TBL] [Abstract][Full Text] [Related]
2. Ligand-induced peroxisome proliferator-activated receptor alpha conformational change.
Dowell P; Peterson VJ; Zabriskie TM; Leid M
J Biol Chem; 1997 Jan; 272(3):2013-20. PubMed ID: 8999894
[TBL] [Abstract][Full Text] [Related]
3. cis-parinaric acid is a ligand for the human peroxisome proliferator activated receptor gamma: development of a novel spectrophotometric assay for the discovery of PPARgamma ligands.
Palmer CN; Wolf CR
FEBS Lett; 1998 Jul; 431(3):476-80. PubMed ID: 9714568
[TBL] [Abstract][Full Text] [Related]
4. Ligand selectivity of the peroxisome proliferator-activated receptor alpha.
Lin Q; Ruuska SE; Shaw NS; Dong D; Noy N
Biochemistry; 1999 Jan; 38(1):185-90. PubMed ID: 9890897
[TBL] [Abstract][Full Text] [Related]
5. The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.
Sapone A; Peters JM; Sakai S; Tomita S; Papiha SS; Dai R; Friedman FK; Gonzalez FJ
Pharmacogenetics; 2000 Jun; 10(4):321-33. PubMed ID: 10862523
[TBL] [Abstract][Full Text] [Related]
6. The important role of residue F268 in ligand binding by LXRbeta.
Urban F; Cavazos G; Dunbar J; Tan B; Escher P; Tafuri S; Wang M
FEBS Lett; 2000 Nov; 484(2):159-63. PubMed ID: 11068052
[TBL] [Abstract][Full Text] [Related]
7. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
[TBL] [Abstract][Full Text] [Related]
8. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
Schoonjans K; Staels B; Auwerx J
Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
[TBL] [Abstract][Full Text] [Related]
10. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha.
Bogan AA; Dallas-Yang Q; Ruse MD; Maeda Y; Jiang G; Nepomuceno L; Scanlan TS; Cohen FE; Sladek FM
J Mol Biol; 2000 Sep; 302(4):831-51. PubMed ID: 10993727
[TBL] [Abstract][Full Text] [Related]
11. [Peroxisome proliferator-activated receptor(PPAR)--structure, function, tissue distribution, gene expression].
Takeyama K; Kodera Y; Suzawa M; Kato S
Nihon Rinsho; 2000 Feb; 58(2):357-63. PubMed ID: 10707558
[TBL] [Abstract][Full Text] [Related]
12. Amino acids important for ligand specificity of the human constitutive androstane receptor.
Jyrkkärinne J; Windshügel B; Mäkinen J; Ylisirniö M; Peräkylä M; Poso A; Sippl W; Honkakoski P
J Biol Chem; 2005 Feb; 280(7):5960-71. PubMed ID: 15572376
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-based ligand-binding assays for peroxisome proliferator-activated receptors.
Adamson DJ; Palmer CN
Methods Enzymol; 2002; 357():188-97. PubMed ID: 12424910
[No Abstract] [Full Text] [Related]
14. Modulation of the expression of peroxisome proliferator-activated receptor-dependent genes through disproportional expression of two subtypes in the small intestine.
Mochizuki K; Suruga K; Kitagawa M; Takase S; Goda T
Arch Biochem Biophys; 2001 May; 389(1):41-8. PubMed ID: 11370670
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
16. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz P; Hu E; Graves RA; Budavari AI; Spiegelman BM
Genes Dev; 1994 May; 8(10):1224-34. PubMed ID: 7926726
[TBL] [Abstract][Full Text] [Related]
17. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the mouse peroxisome proliferator-activated receptor delta gene.
Magge SS; Guardiola-Diaz H
Biochem Biophys Res Commun; 2002 Jan; 290(1):230-5. PubMed ID: 11779158
[TBL] [Abstract][Full Text] [Related]
19. Amino acid residues in both the DNA-binding and ligand-binding domains influence transcriptional activity of the human peroxisome proliferator-activated receptor alpha.
Myers KA; Lambe KG; Aldridge TC; Macdonald N; Tugwood JD
Biochem Biophys Res Commun; 1997 Oct; 239(2):522-6. PubMed ID: 9344863
[TBL] [Abstract][Full Text] [Related]
20. [Lipid metabolism related nuclear receptor--the structure, function, expression and classification of peroxisome proliferation-activated receptor (PPAR)].
Kawada T
Nihon Rinsho; 1998 Jul; 56(7):1722-8. PubMed ID: 9702044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
